Expression of HER-2 affects patient survival and paclitaxel sensitivity in endometrial cancer

MLA

Masaki Inoue, et al. “Expression of HER-2 Affects Patient Survival and Paclitaxel Sensitivity in Endometrial Cancer.” British Journal of Cancer, vol. 103, no. 6, July 2010, pp. 889–98. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....10734bf96acc7f94e7f2080f3afd6855&authtype=sso&custid=ns315887.

APA

Masaki Inoue, Satoru Kyo, Yoshiko Maida, Satoshi Ohno, Manabu Hashimoto, Masahiro Takakura, Tohru Kiyono, Noriko Mori, Nakamura Masahito, & Yasunari Mizumoto. (2010). Expression of HER-2 affects patient survival and paclitaxel sensitivity in endometrial cancer. British Journal of Cancer, 103(6), 889–898.

Chicago

Masaki Inoue, Satoru Kyo, Yoshiko Maida, Satoshi Ohno, Manabu Hashimoto, Masahiro Takakura, Tohru Kiyono, Noriko Mori, Nakamura Masahito, and Yasunari Mizumoto. 2010. “Expression of HER-2 Affects Patient Survival and Paclitaxel Sensitivity in Endometrial Cancer.” British Journal of Cancer 103 (6): 889–98. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....10734bf96acc7f94e7f2080f3afd6855&authtype=sso&custid=ns315887.